v3.25.2
Stock Compensation Plans
6 Months Ended
Jun. 30, 2025
Stock Compensation Plans  
Stock Compensation Plans

Note 13 — Stock Compensation Plans

At a special shareholders meeting held on September 29, 2022, the Company’s shareholders approved the Company’s 2022 Equity Incentive Plan whereby 1,369,771 shares of the Company’s common stock were reserved from authorized but unissued shares for purposes of grants of incentive stock options, nonqualified stock options, restricted stock, restricted stock units, performance shares and performance units to selected employees and non-employee directors of the Company.

The product of the number of shares granted and the grant date market price of the Company’s common stock determine the fair value of restricted stock under the Company’s 2022 Equity Incentive Plan. Management recognizes compensation expense for the fair value of restricted stock on a straight-line basis over the requisite service period for the entire award. As of June 30, 2025 and December 31, 2024, there were 102,759 shares available for future awards under this plan, which includes 98,311 shares available for stock options and 4,448 shares available for restricted stock awards.

A summary of the Company’s restricted stock activity and related information for the three and six months ended June 30, 2025 and 2024 follows:

2025

Weighted

Average

    

Shares

    

Market Price

Outstanding at December 31, 2024

234,635

 

$

14.58

Granted

 

Forfeited

 

Vested

 

Outstanding at March 31, 2025

234,635

 

$

14.58

Granted

 

Forfeited

 

Vested

 

Outstanding at June 30, 2025

234,635

$

14.58

2024

Weighted

Average

    

Shares

    

Market Price

Outstanding at December 31, 2023

286,508

 

$

13.72

Granted

 

Forfeited

 

Vested

 

Outstanding at March 31, 2024

286,508

 

$

13.72

Granted

 

Forfeited

 

Vested

 

Outstanding at June 30, 2024

286,508

$

13.72

Compensation expense related to restricted stock was $293,000 and $252,000 for the three months, and $586,000 and $504,000 for the six months ended June 30, 2025 and 2024, respectively. At June 30, 2025 and December 31, 2024, the total compensation cost related to non-vested restricted stock awards that has not yet been recognized was $2.7 million and $3.3 million, respectively, which cost is expected to be recognized over the next three years.

A summary of the Company’s stock option activity and related information for the three and six months ended June 30, 2025 and 2024 follows:

2025

Weighted

Average

    

Options

    

Exercise Price

Outstanding at December 31, 2024

842,896

 

$

13.72

Granted

 

Forfeited

 

Exercised

14,480

 

12.40

Outstanding at March 31, 2025

828,416

$

13.74

Exercisable at March 31, 2025

322,078

13.78

Granted

 

Forfeited

 

Exercised

 

Outstanding at June 30, 2025

828,416

$

13.74

Exercisable at June 30, 2025

322,078

13.78

2024

Weighted

Average

    

Options

    

Exercise Price

Outstanding at December 31, 2023

880,097

 

$

13.67

Granted

 

Forfeited

 

Exercised

1,000

 

14.08

Outstanding at March 31, 2024

879,097

$

13.67

Exercisable at March 31, 2024

175,019

13.67

Granted

 

Forfeited

 

Exercised

 

Outstanding at June 30, 2024

879,097

$

13.67

Exercisable at June 30, 2024

175,019

13.67

Compensation cost related to stock options is recognized based on the fair value of the stock options at the grant date on a straight-line basis over the vesting period. Compensation expense related to stock options was $186,000 and $192,000 for the three months, and $371,000 and $384,000 for the six months ended June 30, 2025 and 2024, respectively. At June 30, 2025 and December 31, 2024, unrecognized compensation cost related to stock option awards was $1.8 million and $2.1 million, respectively, which is expected to be recognized over the next three years.